
Director of R&D at Lonza
Washington D.C. Metro Area

Director of R&D at Lonza
Washington D.C. Metro Area
I am an experienced R&D scientist and engineer that has excelled in both basic and applied research environments. A keen interest in technology management has led me to explore applying Technology Roadmapping principles to the world of Cell Therapy. I worked in an FDA regulated environment while managing process and product development programs at a clinical-stage stem cell therapy company. I take a project management approach to directing projects and resources, and am very results oriented. I consider myself a student of leadership and continuously practice building, coaching, and developing a team of diverse individuals. I have a strong interest in IP and patent strategy, and am a continuous learner with several outside interests. Technology and Innovation Management as it relates to cell-based products is where I am currently building my skill sets. A proper work-life balance is very important to me.
Technology Roadmapping, Cell Therapy Biomanufacturing, Biomaterials, Tissue Engineering, Stem Cell Therapeutics, Cell Therapy-specific BioProcess Development, Patent Strategy and IP Protection, Open Innovation, Science Blogging
(Public Company; 5001-10,000 employees; LONN; Biotechnology industry)
March 2008 — Present (1 year 9 months)
(Public Company; 51-200 employees; ASTM; Biotechnology industry)
July 2005 — February 2008 (2 years 8 months)
•Coaching and development of 7+ staff in methods, process, and formulation development activities
•Responsible for product development, differentiation, and clinical cell delivery across therapeutic indications
•Responsible for bioprocess development (including cryopreservation and extended shelf-life) and manufacturing improvements
•Actively managing development and execution of IP strategy to update and protect technology portfolio
(Public Company; BDX; Biotechnology industry)
May 2001 — June 2005 (4 years 2 months)
•Managed 5+ researchers in biomaterials technology, tissue engineering, novel transfection systems, bioreactor design, and lab automation
•Developed high throughput 3-D dynamic culture system to support tissue engineering/drug discovery projects
•Provided IP and technical diligence for business development and corporate strategy
•Collaboration and scientific manager for several external research and development programs
•Authored 15 Invention Disclosures, with 9 resulting in filed patent applications
(Biotechnology industry)
1998 — 1998 (less than a year)
BSE, MS, PhD , Materials Science & Engineering, Biomedical Engineering , 1990 — 2001
•Research Focus: Designing biomaterials to control cell function and engineered tissue development:
-New materials were licensed and developed pre-clinically at Curis, Inc.
-IP now owned and materials commercialized by FMC Biopolymer, with
whom I scientifically consult
•15 publications, 4 patent apps., 3 issued patents, and 23 national meeting presentations
•Created novel biomaterial systems for studying cell adhesion, cell mechanics, and scaffold interactions
•Developed cell-based system for investigating signals controlling growth and differentiation in muscle cells
•Extensively interacted with industry and academic collaborators outside UM
•Awarded competitive training fellowships:
GAANN Fellowship (1995–1996)
Cellular Biotechnology Training Fellowship (2000–2001)
Managing Technology and Innovation, Technology Roadmapping, Regenerative Medicine, Cell-based Therapies including Tissue Engineering, Stem Cells, Biomanufacturing, Biomaterials, Leadership, Intellectual Property, Mountain Biking and Vegetable Gardening
Editor of The Regeneration Station, Program Chair for the Cell Therapy SIG of the Society for Biomaterials, Guest editing a special issue of the journal Tissue Engineering related to "Environments for Guiding Stem Cell Functions", Chairing Stem Cell sessions for Biomedical Engineering Society